Seth Klarman - Baupost Group
Holding/activity history for Pdl Biopharma Inc (PDLI)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2012 Q1 | 0 | 0.00 | Sell 100.00% | 1.70 | SEC | ||
| 2011 Q4 | 8,000,000 | 1.70 | Reduce 48.84% | 1.59 | $6.20 | $49,600,000 | SEC |
| 2011 Q3 | 15,636,000 | 3.26 | Add 68.81% | 1.33 | $5.55 | $86,780,000 | SEC |
| 2011 Q2 | 9,262,325 | 2.68 | Reduce 11.75% | 0.53 | $5.87 | $54,370,000 | SEC |
| 2011 Q1 | 10,495,225 | 4.51 | Add 87.30% | 2.10 | $5.80 | $60,872,000 | SEC |
| 2010 Q4 | 5,603,400 | 2.67 | Buy | 2.67 | $6.23 | $34,909,000 | SEC |
| 2009 Q3 | 0 | 0.00 | Sell 100.00% | 11.85 | SEC | ||
| 2009 Q2 | 12,657,500 | 11.85 | Reduce 18.65% | 2.97 | $7.90 | $99,994,000 | SEC |
| 2009 Q1 | 15,559,608 | 15.90 | Add 8.33% | 1.22 | $7.08 | $110,162,000 | SEC |
| 2008 Q4 | 14,363,749 | 11.90 | Add 3.63% | 0.42 | $6.18 | $88,768,000 | SEC |
| 2008 Q3 | 13,860,460 | 11.47 | Reduce 6.51% | 0.91 | $9.31 | $129,041,000 | SEC |
| 2008 Q2 | 14,825,000 | 14.03 | Add 3,111.66% | 13.59 | $10.62 | $157,442,000 | SEC |
| 2008 Q1 | 461,600 | 0.57 | Buy | 0.57 | $10.59 | $4,888,000 | SEC |